You have 9 free searches left this month | for more free features.

City

Condition

Thymidine Kinase 2 Deficiency (1)

Overall Status

Withdrawn (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Modis Therapeutics, Inc. (1)

Collaborator

Zogenix, Inc. (1)

Intervention

mt1621 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

mt1621

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Thymidine Kinase 2 Deficiency Trial (MT1621)

Withdrawn

Thymidine Kinase 2 Deficiency

MT1621

(no location specified)

Aug 16, 2022